-transparent.png){kind=logo}
Setoperone (R 52245), a serotonin S2 and dopamine D2 receptor blocker, was tested on eight healthy male volunteers, receiving 5 or 40 mg orally, in order to assess the modifications of plasma prolactin levels, as an index of receptor blocking activity. Both doses significantly increased plasma levels, confirming the dopamine blocking activity. In vitro and in vivo studies have shown serotonin S2 receptor blockade and lysergic acid diethylamide antagonist activity. Setoperone is proposed as a possible new neuroleptic drug.
Related Publications
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
February 1987,
Pharmacopsychiatry,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
January 1969,
Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
April 1965,
Deutsches medizinisches Journal,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
October 1966,
Neurologia, neurochirurgia i psychiatria polska,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
December 1960,
Der Nervenarzt,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
January 1981,
Arzneimittel-Forschung,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
January 1989,
Acta psychiatrica Scandinavica. Supplementum,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
December 1963,
Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
October 2005,
Prescrire international,
G Meco, and
L Lestingi, and
M G Buzzi, and
P Petrini, and
V Pasqualoni, and
P Falaschi, and
S Marini
January 1985,
Advances in biochemical psychopharmacology,
